                         SEQUENCE LISTING

<110>  GEBEYEHU, Gulilat
       JESSEE, Joel
 
<120>  POLYCATIONIC METHYL PHOSPHOLIPIDS FOR IMPROVEDDELIVERY OF NUCLEIC
        ACIDS TO EUKARYOTIC CELLS

<130>  MTI.001PCT

<150>  61/719,932
<151>  2012-10-29

<160>  31    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  1

Gly Tyr Ser Thr Pro Pro Lys Lys Lys Arg Lys Val Glu Asp Pro 
1               5                   10                  15  


<210>  2
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  2

Gly Tyr Ser Thr Pro Pro Lys Thr Arg Arg Arg Pro 
1               5                   10          


<210>  3
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  3

Gly Tyr Ser Thr Pro Gly Arg Lys Lys Arg 
1               5                   10  


<210>  4
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  4

Gly Tyr Ser Thr Pro Arg Arg Asn Arg Arg Arg Arg Trp 
1               5                   10              


<210>  5
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  5

Pro Asp Glu Val Lys Arg Lys Lys Lys Pro Pro Thr Ser Tyr Gly 
1               5                   10                  15  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  6

Pro Arg Arg Arg Thr Lys Pro Pro Thr Ser Tyr Gly 
1               5                   10          


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  7

Arg Lys Lys Arg Gly Pro Thr Ser Tyr Gly 
1               5                   10  


<210>  8
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  8

Trp Arg Arg Arg Arg Asn Arg Arg Pro Thr Ser Tyr Gly 
1               5                   10              


<210>  9
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide


<220>
<221>  misc_feature
<222>  (18)..(18)
<223>  Xaa = (K)8-40

<400>  9

Gly Tyr Gly Pro Pro Lys Lys Lys Arg Lys Val Glu Ala Pro Tyr Lys 
1               5                   10                  15      


Ala Xaa Lys 
            


<210>  10
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  10

Phe Glu Ala Ala Leu Ala Glu Ala Leu Ala Glu Ala Leu Ala 
1               5                   10                  


<210>  11
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  11

Leu Ala Arg Leu Leu Pro Arg Leu Leu Ala Arg Leu 
1               5                   10          


<210>  12
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  12

Gly Leu Leu Glu Glu Leu Leu Glu Leu Leu Glu Glu Leu Trp Glu Glu 
1               5                   10                  15      


Leu Leu Glu Gly 
            20  


<210>  13
<211>  19
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  13

Gly Trp Glu Gly Leu Ile Glu Gly Ile Glu Gly Gly Trp Glu Gly Leu 
1               5                   10                  15      


Ile Glu Gly 
            


<210>  14
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  14

Gly Leu Phe Glu Ala Leu Ala Glu Phe Ile Glu Gly Gly Trp Glu Gly 
1               5                   10                  15      


Leu Ile Glu Gly 
            20  


<210>  15
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  15

Gly Leu Phe Glu Ala Leu Leu Glu Leu Leu Glu Ser Leu Trp Glu Leu 
1               5                   10                  15      


Leu Leu Glu Ala 
            20  


<210>  16
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  16

Gly Gly Tyr Cys Leu Glu Lys Trp Met Ile Val Ala Ser Glu Leu Lys 
1               5                   10                  15      


Cys Phe Gly Asn Thr Ala 
            20          


<210>  17
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  17

Gly Gly Tyr Cys Leu Thr Arg Trp Met Leu Ile Glu Ala Glu Leu Lys 
1               5                   10                  15      


Cys Phe Gly Asn Thr Ala Val 
            20              


<210>  18
<211>  30
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  18

Trp Glu Ala Ala Leu Ala Glu Ala Leu Ala Glu Ala Leu Ala Glu His 
1               5                   10                  15      


Leu Ala Glu Ala Leu Ala Glu Ala Leu Glu Ala Leu Ala Ala 
            20                  25                  30  


<210>  19
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  19

Ile Asn Ile Gly Thr Thr Gly Trp Gly Asp His Tyr Ser Leu Tyr 
1               5                   10                  15  


<210>  20
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  20

Ala Ala Arg Ser Pro Ser Tyr Tyr Arg Tyr Asp Tyr Gly Pro Tyr Tyr 
1               5                   10                  15      


Ala Met Asp Tyr Asp 
            20      


<210>  21
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  21

Gly Ala Cys Ser Glu Arg Ser Met Asn Phe Cys Gly 
1               5                   10          


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  22

Gly Ala Cys Tyr Gly Leu Pro His Lys Phe Cys Gly 
1               5                   10          


<210>  23
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  23

Tyr Tyr Cys Gln Gln Arg Ser Ser Tyr Pro Tyr Thr Phe Gly Gly 
1               5                   10                  15  


<210>  24
<211>  22
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  24

Thr Arg Gln Ala Arg Arg Asn Arg Arg Arg Arg Trp Arg Glu Arg Gln 
1               5                   10                  15      


Arg Gly Ser Gly Ser Gly 
            20          


<210>  25
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  25

Arg Asp Trp Ser Ser Gln His Pro Gly Arg Cys Asn Gly Glu Thr His 
1               5                   10                  15      


Leu Lys 
        


<210>  26
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  26

Gly Gly Gly Asp Tyr Tyr Cys Ala Ala Trp Asp Asp Ser Leu Asn Gly 
1               5                   10                  15      


Tyr Ser Val Phe 
            20  


<210>  27
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  27

Val Ile Val Thr Gly Gly Asp Tyr Ser Phe Ala Leu Pro Val Gly Gln 
1               5                   10                  15      


Trp Pro Val Met Thr Gly Gly Ala 
            20                  


<210>  28
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  28

Asp Lys Pro Ser Tyr Gln Phe Gly Gly His Asn Ser Val Asp Phe Glu 
1               5                   10                  15      


Glu Asp Thr Leu Pro Lys Val 
            20              


<210>  29
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  29

His Leu Arg Arg Leu Arg Arg Arg Leu Leu Arg Glu Ala Glu Gly 
1               5                   10                  15  


<210>  30
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  30

Tyr Tyr Cys Ala Arg Ser Gly Tyr Tyr Ala Met Asp Tyr Trp Gly Gln 
1               5                   10                  15      


Gly Thr 
        


<210>  31
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Artificial peptide

<400>  31

Gly Lys Trp Glu Arg Lys Pro Ile Arg Cys Ala Ser 
1               5                   10          


